Leveraging Neoadjuvant and Adjuvant Immunotherapy to Break Through the Outcomes Plateau, Prevent Recurrences, and Improve Curability in Early-Stage Cancers
1.50 hr(s) | ABIM , CME , CPE , MOC , NCPD , Royal College of Physicians and Surgeons of Canada
Specialty: Early-stage Cancers
Therapeutic Area(s): Oncology
Release Date: December 23, 2021
Expiration Date: December 22, 2022
Location: Internet Activity Enduring
In this activity, multidisciplinary oncology experts discuss immunotherapy advances, focusing on transitioning immunotherapies to earlier disease settings to improve outcomes, prevent recurrences, and increase curability in early-stage cancers.